Health Highlights, Nov. 9, 2020
Below are newsworthy items compiled by the HealthDay staff:
Medicare Outpatient Premium to Rise
The Medicare Part B premium for outpatient care will increase next year, and so will the deductible, Medicare officials announced Friday.
The monthly premium for outpatient care will rise by $3.90 next year to $148.50, which will claim 20% of the average retired worker's Social Security cost-of-living adjustment of $20 a month next year, the Associated Press reported.
Under law, the Part B premium must cover about 25% of the cost of Medicare's supplemental insurance for outpatient services.
There will be a $5 increase in the Part B deductible, bringing it to $203 next year. The inpatient deductible will increase $76 to $1,484, the AP reported.
Panel Recommends Against Approval of Experimental Alzheimer's Drug
An experimental Alzheimer's disease treatment should not be approved by the U.S. Food and Drug Administration, an agency advisory panel says.
The panel reviewed clinical data on the drug aducanumab and concluded that there's not enough evidence to support its clinical effectiveness, CNN reported.
The drug, developed by the pharmaceutical company Biogen and its Japanese partner Eisai, is administered through intravenous infusion for early Alzheimer's disease.
"There's a huge danger in approving something that turns out not to be effective," said panel member Dr. Joel Perlmutter said in Friday's meeting, CNN reported.
"If we approve something when the data is not strong, we have a risk of delaying good treatments and effective treatments for more than a couple of years, for many years," Perlmutter said.
The panel's recommendation will be taken into account by the FDA as it decides whether or not to approve the drug. It's been nearly 20 years since the agency approved a new Alzheimer's drug, CNN reported.
© 2021 HealthDay. All rights reserved.
Posted: November 2020
Read this next
TUESDAY, Jan. 26, 2021 -- All Alzheimer's disease patients and their family caregivers should be vaccinated against COVID-19, the Alzheimer's Foundation of America says. "Getting...
THURSDAY, Jan. 21, 2021 (American Heart Association News) -- Mental decline is one of the most feared aspects of growing older. People will do just about anything to prevent it,...
WEDNESDAY, Jan. 13, 2021 -- A rare brain disease that causes loss of language skills doesn't lead to memory loss, a new study finds. The condition is called primary progressive...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.